Workflow
华宝基金管理有限公司
icon
Search documents
华厦眼科股价跌1.04%,华宝基金旗下1只基金位居十大流通股东,持有713.88万股浮亏损失135.64万元
Xin Lang Cai Jing· 2025-12-30 05:26
Group 1 - The core point of the news is that Huaxia Eye Hospital's stock has experienced a decline of 1.04%, with a total market value of 15.128 billion yuan and a cumulative drop of 0.6% over the last three days [1] - Huaxia Eye Hospital Group, established on August 12, 2004, specializes in ophthalmology services, with revenue composition as follows: refractive projects 36.90%, comprehensive optometry projects 24.04%, cataract projects 20.14%, posterior segment projects 12.94%, and others 5.99% [1] - The stock's trading volume was 36.5619 million yuan, with a turnover rate of 0.31% [1] Group 2 - Huaxia Eye Hospital's major circulating shareholder is Huabao Fund, which reduced its holdings in the Huabao CSI Medical ETF (512170) by 1.1664 million shares, now holding 7.1388 million shares, representing 2.17% of circulating shares [2] - The estimated floating loss for Huabao CSI Medical ETF today is approximately 1.3564 million yuan, with a cumulative floating loss of 785,300 yuan during the three-day decline [2] - The Huabao CSI Medical ETF was established on May 20, 2019, with a current scale of 26.404 billion yuan and a year-to-date return of 5.42%, ranking 3760 out of 4195 in its category [2]
中科软股价涨1%,华宝基金旗下1只基金位居十大流通股东,持有942.31万股浮盈赚取179.04万元
Xin Lang Cai Jing· 2025-12-30 02:50
Group 1 - Zhongke Soft Technology Co., Ltd. experienced a 1% increase in stock price, reaching 19.17 CNY per share, with a trading volume of 65.62 million CNY and a turnover rate of 0.41%, resulting in a total market capitalization of 15.93 billion CNY [1] - The company, established on May 30, 1996, and listed on September 9, 2019, primarily engages in computer software development, sales, and services. The revenue composition includes 71.83% from software development and services, 26.63% from system integration and services, 1.29% from software products, and 0.26% from other sources [1] Group 2 - Among the top ten circulating shareholders of Zhongke Soft, Huabao Fund's Huabao CSI Financial Technology Theme ETF (159851) entered the list in the third quarter, holding 9.42 million shares, which accounts for 1.13% of circulating shares, with an estimated floating profit of approximately 1.79 million CNY [2] - The Huabao CSI Financial Technology Theme ETF was established on March 4, 2021, with a current scale of 12.32 billion CNY. Year-to-date returns are 17.4%, ranking 2980 out of 4195 in its category; the one-year return is 11.8%, ranking 3261 out of 4179; and since inception, the return is 68.04% [2] Group 3 - The fund managers of Huabao CSI Financial Technology Theme ETF are Chen Jianhua and Cao Xucheng. Chen has a cumulative tenure of 13 years and 12 days, with a total fund asset scale of 27.70 billion CNY, achieving a best fund return of 177.41% and a worst return of -49.65% during his tenure [3] - Cao has a cumulative tenure of 223 days, managing a total fund asset scale of 35.18 billion CNY, with a best fund return of 113.5% and a worst return of -9.3% during his tenure [3]
三诺生物股价跌1.04%,华宝基金旗下1只基金位居十大流通股东,持有961.42万股浮亏损失173.06万元
Xin Lang Cai Jing· 2025-12-30 02:20
Core Viewpoint - Sanofi Bio's stock decreased by 1.04% to 17.13 CNY per share, with a total market capitalization of 9.597 billion CNY as of the report date [1] Group 1: Company Overview - Sanofi Bio was established on August 7, 2002, and went public on March 19, 2012 [1] - The company specializes in the research, design, production, and sales of point-of-care testing (POCT) products for chronic disease detection [1] - The revenue composition of Sanofi Bio includes: 73.29% from blood glucose monitoring systems, 6.59% from diabetes nutrition and care products, 5.03% from glycated hemoglobin testing systems, 4.14% from blood lipid testing systems, 4.11% from blood pressure monitors, 3.94% from iPOCT monitoring systems, 2.05% from other products, and 0.85% from miscellaneous [1] Group 2: Shareholder Information - Huabao Fund's Huabao CSI Medical ETF (512170) is among the top ten circulating shareholders of Sanofi Bio, having reduced its holdings by 1.5068 million shares in the third quarter, now holding 9.6142 million shares, which is 2.13% of the circulating shares [2] - The estimated floating loss for Huabao CSI Medical ETF today is approximately 1.7306 million CNY [2] - The fund was established on May 20, 2019, with a current size of 26.404 billion CNY, yielding 5.42% this year, ranking 3760 out of 4195 in its category [2]
12月29日港股信息技术ETF(159131)份额减少200.00万份
Xin Lang Cai Jing· 2025-12-30 01:10
Group 1 - The Hong Kong Information Technology ETF (159131) experienced a decline of 0.66% on December 29, with a trading volume of 58.2683 million yuan [1] - The fund's shares decreased by 2 million, bringing the total shares to 302 million, while the shares increased by 9 million over the last 20 trading days [1] - The latest net asset value of the fund is calculated to be 273 million yuan [1] Group 2 - The performance benchmark for the Hong Kong Information Technology ETF is the China Securities Hong Kong Stock Connect Information Technology Composite Index return adjusted for the RMB exchange rate [1] - The fund is managed by Hua Bao Fund Management Co., Ltd., with fund managers Cao Xuchen and Zhang Fang [1] - Since its establishment on November 5, 2025, the fund has returned -9.72%, with a one-month return of -2.87% [1]
重亏近50%遭解聘?基金经理将华宝基金告上法庭
凤凰网财经· 2025-12-29 13:03
Core Viewpoint - The article discusses a labor dispute involving Huabao Fund, which has led to a court case set for January 19, 2026, involving a former fund manager named Chen Long [3][4]. Group 1: Labor Dispute - Huabao Fund is being sued by Chen Long for a labor dispute, with the case scheduled to be heard in the Shanghai High People's Court [3][4]. - Chen Long, a former senior analyst and fund manager at Huabao Fund, left his positions in two funds in 2024 due to poor performance and business adjustments [7][9]. Group 2: Fund Performance - During Chen Long's tenure, the Huabao Competitive Advantage Mixed Fund had a return rate of -46.75%, while the Huabao Green Theme Mixed Fund saw a decline of over 50%, with a return rate of -54.80% [9][11]. - After Chen Long's departure, the Huabao Competitive Advantage Mixed Fund experienced a significant increase, achieving a return of 63.07% in 2025, ranking in the top 10% of similar products [10][12]. Group 3: Management Changes - Chen Long was replaced by Shi Jian as the fund manager on September 23, 2023, who has since focused on investing in domestic semiconductor sectors [11][12]. - Huabao Fund's total management scale reached 379.1 billion yuan, ranking 28th in the industry as of September [12].
因“劳动争议”,华宝前基金经理怒告老东家?
Shen Zhen Shang Bao· 2025-12-29 12:50
Core Viewpoint - Huabao Fund is facing a labor dispute lawsuit filed by Chen Long, with the case accepted by the Shanghai Pudong New District People's Court, scheduled for a hearing on January 19, 2026 [1][2]. Group 1: Legal Proceedings - The lawsuit against Huabao Fund is categorized as a labor dispute, with the case number being (2025) Hu 0115 Min [2]. - The hearing is set for January 19, 2026, at 14:30 [2]. Group 2: Chen Long's Tenure and Performance - Chen Long worked at Huabao Fund from September 2018 and managed products from September 2, 2021, until his resignation on April 9, 2024, with a total tenure of 3 years and 62 days [3]. - During his management, the net asset values of the funds he managed decreased significantly, with Huabao Green Theme Mixed Fund dropping by 54.8% and Huabao Competitive Advantage Mixed Fund by 46.75% [3]. - The Huabao Green Theme Mixed Fund was liquidated due to its net asset value falling below 50 million RMB for 60 consecutive working days, shrinking from approximately 56 million RMB to 13 million RMB during Chen Long's management [4]. Group 3: Fund Performance and Management Changes - In 2024, Huabao Fund had a total of 9 products liquidated, with most of them showing negative returns since inception; in the current year, 9 products have also been liquidated, with 3 having negative returns [4]. - Huabao Fund currently employs 43 fund managers, significantly exceeding the industry average of about 24, with an average tenure of 3 years and 84 days [4]. - The recent two years saw only 4 fund managers leaving Huabao Fund, while 3 new hires were made [4]. Group 4: Current Fund Performance - As of the third quarter, Huabao Fund manages a total of 161 products with a combined scale of 401.25 billion RMB, ranking 28th in the industry [5]. - The fund's performance has improved in 2024, with several products achieving returns exceeding 100%, while some equity funds have reported negative returns [5]. - Over a three-year period, several actively managed equity funds from Huabao Fund have underperformed against their benchmarks, with declines exceeding 20% in net value for some products [6].
华宝基金这瓜,越吃越觉得苦涩
Xin Lang Cai Jing· 2025-12-29 11:30
Core Viewpoint - The article discusses the legal dispute between former fund manager Chen Long and Huabao Fund, highlighting the harsh realities of the public fund industry, where performance is paramount and underperformance can lead to dismissal [1][10]. Group 1: Legal Dispute - Chen Long has filed a lawsuit against Huabao Fund due to a labor contract dispute, with the court date set for January 19, 2026 [1][8]. - The lawsuit reflects broader issues in the public fund industry, particularly the "performance-based elimination" culture [1][10]. Group 2: Chen Long's Background and Performance - Chen Long has a notable background, having worked at Tianxiang Investment Consulting, Minsheng Securities, and China International Capital Corporation before joining Huabao Fund in September 2018 [2][14]. - He managed two funds, the Huabao Green Theme Mixed Fund and the Huabao Competitive Advantage Mixed Fund, during a time when the "carbon neutrality" concept was gaining traction [3][14]. - Despite initial promise, both funds experienced significant losses, with the Huabao Green Theme Mixed Fund losing 54.8% and the Huabao Competitive Advantage Mixed Fund losing 46.75% during his tenure [5][16]. Group 3: Fund Performance and Market Reaction - In the last three months of his tenure, the funds saw a sudden performance increase, with a 21.75% rise, outperforming the benchmark by nearly 10 percentage points [5][16]. - After Chen's departure, the new fund manager shifted the investment focus to AI computing and other hot sectors, resulting in a 63% return for the fund in 2024, contrasting sharply with Chen's performance [7][18]. Group 4: Industry Context and Implications - The article notes a trend in the public fund industry where fund managers face increasing pressure, with average tenure dropping below 2.5 years due to intense competition [9][19]. - Chen Long's case serves as a warning for the industry, questioning the sustainability of investment philosophies in an environment where performance is closely tied to job security [10][19].
关于同意东海证券股份有限公司为华宝港股通恒生中国(香港上市)30交易型开放式指数证券投资基金提供主做市服务的公告
Xin Lang Cai Jing· 2025-12-29 09:58
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 上证公告(基金)【2025】2697号 为促进华宝港股通恒生中国(香港上市)30交易型开放式指数证券投资基金(以下简称香港30,基 金代码:520560)的市场流动性和平稳运行,根据《上海证券交易所基金自律监管规则适用指引第2号 ——上市基金做市业务》等相关规定,本所同意东海证券股份有限公司自2025年12月30日起为香港30提 供主做市服务。 特此公告。 上海证券交易所 2025年12月29日 ...
重亏近50%遭解聘?基金经理将华宝基金告上法庭
Group 1 - Huabao Fund has been sued in court due to a labor dispute, with the case set to be heard on January 19, 2026 [1][4] - The plaintiff, Chen Long, is linked to a former fund manager at Huabao Fund, who served as a senior analyst and managed multiple funds before leaving [5][7] - Chen Long's performance as a fund manager was poor, with returns of -46.75% for the Huabao Competitive Advantage Mixed Fund and -54.80% for the Huabao Green Theme Mixed Fund during his tenure [7][8] Group 2 - After Chen Long's departure, the Huabao Competitive Advantage Mixed Fund saw a significant increase in returns, achieving 63.07% since 2025, ranking in the top 10% of similar products [8][9] - The current fund manager, Shi Jian, has shifted the fund's focus towards domestic semiconductor investments, which have recently experienced a market surge [8][9] - As of September 30, Huabao Fund's total management scale reached 379.1 billion yuan, ranking 28th in the industry [9]
拉卡拉股价涨5.25%,华宝基金旗下1只基金位居十大流通股东,持有923.18万股浮盈赚取1144.74万元
Xin Lang Cai Jing· 2025-12-29 05:25
12月29日,拉卡拉涨5.25%,截至发稿,报24.86元/股,成交10.09亿元,换手率5.65%,总市值193.08亿 元。 资料显示,拉卡拉支付股份有限公司位于北京市海淀区北清路中关村壹号D1座6层606,香港铜锣湾勿地 臣街1号时代广场2座31楼,成立日期2005年1月6日,上市日期2019年4月25日,公司主营业务涉及为实 体小微企业提供收单服务和为个人用户提供个人支付服务,此外拉卡拉还以积累的丰富第三方支付运营 经验,向客户提供第三方支付增值服务。主营业务收入构成为:支付业务100.00%。 华宝中证金融科技主题ETF(159851)基金经理为陈建华、曹旭辰。 截至发稿,陈建华累计任职时间13年11天,现任基金资产总规模277.02亿元,任职期间最佳基金回报 177.41%, 任职期间最差基金回报-49.65%。 从拉卡拉十大流通股东角度 数据显示,华宝基金旗下1只基金位居拉卡拉十大流通股东。华宝中证金融科技主题ETF(159851)三 季度增持446.12万股,持有股数923.18万股,占流通股的比例为1.26%。根据测算,今日浮盈赚取约 1144.74万元。 华宝中证金融科技主题ETF(159 ...